Zoetis Inc. (ZTS) suffered a pre-market plunge of 7.41% on Thursday, as the animal healthcare company's 2025 profit and revenue forecasts fell short of Wall Street estimates.
Zoetis projected adjusted earnings per share for 2025 to be between $6.00 and $6.10, missing analysts' average estimate of $6.29. The company also guided for full-year revenue in the range of $9.23 billion to $9.38 billion, lower than the consensus estimate of $9.57 billion. The disappointing outlook was partly attributed to the impact of a stronger dollar and the divestiture of certain product portfolios.
Despite the weak guidance, Zoetis reported better-than-expected results for the fourth quarter. Adjusted earnings of $1.40 per share exceeded expectations of $1.34, while revenue rose 5% year-over-year to $2.32 billion, slightly above estimates. However, the market's focus appears to be on the company's muted outlook for 2025, leading to the steep pre-market decline.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。